A comprehensive review on alpha-lipoic acid delivery by nanoparticles

Alpha-lipoic acid (ALA) has garnered significant attention for its potential therapeutic benefits across a wide spectrum of health conditions. Despite its remarkable antioxidant properties, ALA is hindered by challenges such as low bioavailability, short half-life, and unpleasant odor. To overcome t...

Full description

Saved in:
Bibliographic Details
Main Authors: Navid Mosallaei, Amirhossein Malaekeh-Nikouei, Setayesh Sarraf Shirazi, Javad Behmadi, Bizhan Malaekeh-Nikouei
Format: Article
Language:English
Published: Tabriz University of Medical Sciences 2024-11-01
Series:BioImpacts
Subjects:
Online Access:https://bi.tbzmed.ac.ir/PDF/bi-14-30136.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832595625141600256
author Navid Mosallaei
Amirhossein Malaekeh-Nikouei
Setayesh Sarraf Shirazi
Javad Behmadi
Bizhan Malaekeh-Nikouei
author_facet Navid Mosallaei
Amirhossein Malaekeh-Nikouei
Setayesh Sarraf Shirazi
Javad Behmadi
Bizhan Malaekeh-Nikouei
author_sort Navid Mosallaei
collection DOAJ
description Alpha-lipoic acid (ALA) has garnered significant attention for its potential therapeutic benefits across a wide spectrum of health conditions. Despite its remarkable antioxidant properties, ALA is hindered by challenges such as low bioavailability, short half-life, and unpleasant odor. To overcome these limitations and enhance ALA's therapeutic efficacy, various nanoparticulate drug delivery systems have been explored. This comprehensive review evaluates the application of different nanoparticulate carriers, including lipid-based nanoparticles (solid lipid nanoparticles, niosomes, liposomes, nanostructured lipid carriers (NLCs), and micelles), nanoemulsions, polymeric nanoparticles (nanocapsules, PEGylated nanoparticles, and polycaprolactone nanoparticles), films, nanofibers, and gold nanoparticles, for ALA delivery. Each nanoparticulate system offers unique advantages, such as improved stability, sustained release, enhanced bioavailability, and targeted delivery. For example, ALA-loaded SLNs demonstrated benefits for skin care products and skin rejuvenation. ALA encapsulated in niosomes showed potential for treating cerebral ischemia, a condition largely linked to stroke. ALA-loaded cationic nanoemulsions showed promise for ophthalmic applications, reducing vascular injuries, and corneal disorders. Coating liposomes with chitosan further enhanced stability and performance, promoting drug absorption through the skin. This review provides a comprehensive overview of the advancements in nanoparticulate delivery systems for ALA, highlighting their potential to overcome the limitations of ALA administration and significantly enhance its therapeutic effectiveness. These innovative approaches hold promise for the development of improved ALA-based treatments across a broad spectrum of health conditions.
format Article
id doaj-art-8100ba5d4cd247a094964fba4b82a5e6
institution Kabale University
issn 2228-5652
2228-5660
language English
publishDate 2024-11-01
publisher Tabriz University of Medical Sciences
record_format Article
series BioImpacts
spelling doaj-art-8100ba5d4cd247a094964fba4b82a5e62025-01-18T10:05:19ZengTabriz University of Medical SciencesBioImpacts2228-56522228-56602024-11-01146301363013610.34172/bi.2024.30136bi-30136A comprehensive review on alpha-lipoic acid delivery by nanoparticlesNavid Mosallaei0Amirhossein Malaekeh-Nikouei1Setayesh Sarraf Shirazi2Javad Behmadi3Bizhan Malaekeh-Nikouei4Department of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, ‎Mashhad, IranStudent research committee, School of Pharmacy, Mashhad University of Medical Sciences, ‎Mashhad, IranStudent research committee, School of Pharmacy, Mashhad University of Medical Sciences, ‎Mashhad, IranStudent research committee, School of Pharmacy, Mashhad University of Medical Sciences, ‎Mashhad, IranDepartment of Pharmaceutics, School of Pharmacy, Mashhad University of Medical Sciences, ‎Mashhad, IranAlpha-lipoic acid (ALA) has garnered significant attention for its potential therapeutic benefits across a wide spectrum of health conditions. Despite its remarkable antioxidant properties, ALA is hindered by challenges such as low bioavailability, short half-life, and unpleasant odor. To overcome these limitations and enhance ALA's therapeutic efficacy, various nanoparticulate drug delivery systems have been explored. This comprehensive review evaluates the application of different nanoparticulate carriers, including lipid-based nanoparticles (solid lipid nanoparticles, niosomes, liposomes, nanostructured lipid carriers (NLCs), and micelles), nanoemulsions, polymeric nanoparticles (nanocapsules, PEGylated nanoparticles, and polycaprolactone nanoparticles), films, nanofibers, and gold nanoparticles, for ALA delivery. Each nanoparticulate system offers unique advantages, such as improved stability, sustained release, enhanced bioavailability, and targeted delivery. For example, ALA-loaded SLNs demonstrated benefits for skin care products and skin rejuvenation. ALA encapsulated in niosomes showed potential for treating cerebral ischemia, a condition largely linked to stroke. ALA-loaded cationic nanoemulsions showed promise for ophthalmic applications, reducing vascular injuries, and corneal disorders. Coating liposomes with chitosan further enhanced stability and performance, promoting drug absorption through the skin. This review provides a comprehensive overview of the advancements in nanoparticulate delivery systems for ALA, highlighting their potential to overcome the limitations of ALA administration and significantly enhance its therapeutic effectiveness. These innovative approaches hold promise for the development of improved ALA-based treatments across a broad spectrum of health conditions.https://bi.tbzmed.ac.ir/PDF/bi-14-30136.pdfalpha-lipoic aciddrug deliverynanoparticlesbioavailabilitydrug release
spellingShingle Navid Mosallaei
Amirhossein Malaekeh-Nikouei
Setayesh Sarraf Shirazi
Javad Behmadi
Bizhan Malaekeh-Nikouei
A comprehensive review on alpha-lipoic acid delivery by nanoparticles
BioImpacts
alpha-lipoic acid
drug delivery
nanoparticles
bioavailability
drug release
title A comprehensive review on alpha-lipoic acid delivery by nanoparticles
title_full A comprehensive review on alpha-lipoic acid delivery by nanoparticles
title_fullStr A comprehensive review on alpha-lipoic acid delivery by nanoparticles
title_full_unstemmed A comprehensive review on alpha-lipoic acid delivery by nanoparticles
title_short A comprehensive review on alpha-lipoic acid delivery by nanoparticles
title_sort comprehensive review on alpha lipoic acid delivery by nanoparticles
topic alpha-lipoic acid
drug delivery
nanoparticles
bioavailability
drug release
url https://bi.tbzmed.ac.ir/PDF/bi-14-30136.pdf
work_keys_str_mv AT navidmosallaei acomprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT amirhosseinmalaekehnikouei acomprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT setayeshsarrafshirazi acomprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT javadbehmadi acomprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT bizhanmalaekehnikouei acomprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT navidmosallaei comprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT amirhosseinmalaekehnikouei comprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT setayeshsarrafshirazi comprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT javadbehmadi comprehensivereviewonalphalipoicaciddeliverybynanoparticles
AT bizhanmalaekehnikouei comprehensivereviewonalphalipoicaciddeliverybynanoparticles